Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000

American Journal of Public Health

Volumn 95, Issue 1, 2005, Pages 103-108

  Ünal, Belgin ^a,c   Critchley, Julia A ^a   Fidan, Dogan ^b   Capewell, Simon ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET; FEMALE; HEALTH CARE POLICY; HEART DEATH; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MALE; PHYSICAL ACTIVITY; RISK REDUCTION; SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CORONARY DISEASE; ENGLAND; FEMALE; HUMANS; HYPERTENSION; LIFE EXPECTANCY; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEX DISTRIBUTION; SMOKING; SURVIVAL ANALYSIS; TIME FACTORS; WALES;

EID: 11344264111     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2003.029579     Document Type: Article

References (35)

1. Office for National Statistics. Annual Abstract of Statistics. London, UK: The Stationery Office; 2002.
2. Sackett DL. Evidence-based medicine and treatment choices. Lancet. 1997;349:570-573.
3. Fichtenberg C, Glantz S. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med. 2001;343:1772-1777.
4. McGovera PG, Jacobs DR, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation. 2001;104:19-24.
5. Critchley J, Capewell S. Why model coronary heart disease? Eur Heart J. 2002;23:110-116.
6. Beaglehole R. Medical management and the decline in mortality from coronary heart disease. BMJ. 1986;292:33-35.
7. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997;277:535-542.
8. Capewell S, Beaglehole R, Seddon M, McMurray J. Explaining the decline in coronary heart disease mortality in Auckland, New Zealand between 1982 and 1993. Circulation, 2000;102:1511-1516.
9. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999;81:380-386.
10. Ünal B, Critchley J, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales, 1981-2000. Circulation. 2004;109:1101-1107.
11. Critchley JA, Capewell S, Ünal B. Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment? J Clin Epidemiol. 2003;56:583-590.
12. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547-1557.
13. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med. 2000;342:1-8.
14. Capewell S, Livingston BM, MacIntyre K, et al. Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland. Eur Heart J. 2000;21:1833-1840.
15. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure. Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000;102:1126-1131.
16. Isles CG, Walker LM, Beevers GD, et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens. 1986;4:141-156.
17. Pell JP, MacIntyre K, Walsh D, et al. Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study. BMJ. 2002;324:201-202.
18. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995;346:1184-1189.
19. Tsevat J, Weinstein MC, Williams LW, Tosteson AN, Goldman L. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation. 1991;83:1194-1201.
20. Yudkin JS. How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ. 1993;306:1313-1318.
21. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ. 1994;3:95-104.
22. Grover SA, Paquet S, Levinton C, Coupai L, Zowall H. Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention. Arch Intern Med. 1998;158:655-662.
23. Stewart S, Jenkind A, Buchan S, et al. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail. 2002;4:361-371.
24. Department of Health. National Service Framework for Coronary Heart Disease. 2000. Available at: http://www.doh.gov.uk/pdfs/chdnsf.pdf. Accessed September 12, 2003.
25. Department of Health. Saving Lives: Our Healthier Nation. London, UK: The Stationery Office; 1999.
26. Critchley J, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86-97.
27. The Tobacco Advertising and Promotion Act 2002. Chapter 36 (2002).
28. Smoking Kills: A White Paper on Tobacco. London, UK: The Stationery Office; 1998.
29. Bots ML, Grobbee DE. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors. J Cardiovasc Risk. 1996;3:271-276.
30. Goldman L, Cook E. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825-836.
31. Bunker JP. The role of medical care in contributing to health improvements within societies. Int J Epidemiol. 2001;30:1260-1263.
32. Ünal B, Critchley J, Capewell S. Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease. J Epidemiol Community Health. 2003;57:530-535.
33. British Heart Foundation Statistics Database. Coronary Heart Disease Statistics. 2002. Available at: http://www.bhf.org.uk/professionats/uploaded/ bhf% 20heartstats%202003%20-%204-page.pdf. Accessed September 12, 2003.
34. McAlister FA. Commentary: relative treatment effects are consistent across the spectrum of underlying risks, usually. Int J Epidemiol. 2002;31:76-77.
35. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367-372.